rxstat › Shortages › Inactivated Poliovirus Type Iii Ii I Tetanus Toxoid Diphtheria Pertactin Filamentous Haemagglutinin Pertussis
Inactivated Poliovirus Type Iii Ii I Tetanus Toxoid Diphtheria Pertactin Filamentous Haemagglutinin Pertussis (Infanrix-Ipv) shortage status
Discontinued
A combination vaccine used to protect against diphtheria, tetanus, pertussis and polio.
Reports by product
What's happening
One or more Inactivated Poliovirus Type Iii Ii I Tetanus Toxoid Diphtheria Pertactin Filamentous Haemagglutinin Pertussis products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.
Inactivated Poliovirus Type Iii Ii I Tetanus Toxoid Diphtheria Pertactin Filamentous Haemagglutinin Pertussis is classified under “BACTERIAL AND VIRAL VACCINES, COMBINED” (ATC J07CA).
Recent changes
- No changes recorded yet.
Common questions
What is Inactivated Poliovirus Type Iii Ii I Tetanus Toxoid Diphtheria Pertactin Filamentous Haemagglutinin Pertussis used for?
A combination vaccine used to protect against diphtheria, tetanus, pertussis and polio.
When will Inactivated Poliovirus Type Iii Ii I Tetanus Toxoid Diphtheria Pertactin Filamentous Haemagglutinin Pertussis be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Inactivated Poliovirus Type Iii Ii I Tetanus Toxoid Diphtheria Pertactin Filamentous Haemagglutinin Pertussis in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Related drugs (bacterial and viral vaccines, combined)
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.